-
Supernus Pharma Q1 Loss Per Share $0.60 Vs Loss $6.05 Last Year
5/13/2013
|
-
Supernus Announces Closes $90 Mln Of 7.50% Convertible Senior Secured Notes Due 2019
5/6/2013
|
-
Supernus Prices Offering Of $75 Mln Of 7.50% Convertible Senior Secured Notes Due 2019
4/26/2013
|
-
Supernus Pharmaceuticals Posts Q4 Loss Per Share Of $0.51 Vs. Profit $40.14 Year Ago
3/14/2013
|
|
|
|
|
-
Supernus Appoints Victor Vaughn As SVP, Sales
1/14/2013
|
|
|
-
Supernus Prices Underwritten Public Offering Of 6 Mln Shares At $8/share
11/29/2012
|
-
Supernus Receives Positive Topline Phase IIb Results On SPN-810 For Impulsive Aggression Treatment In ADHD Patients
11/20/2012
|